2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow emactuzumab: new trials by email Literature Review of emactuzumab trials Research Report on emactuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) Emactuzumab, Placebo - TGCT | Phase 3 | Active not recruiting | SynOx Therapeutics Limited | 128 | 2024-10-09 | 2026-07-29 |
| A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study Atezolizumab, Bevacizumab, Alectinib - Cancer | Phase 3 | Active not recruiting | Hoffmann-La Roche | 1000 | 2019-02-28 | 2026-10-22 |
Neoplasms (1) · Synovitis (1) · Synovitis, Pigmented Villonodular (1)
Hoffmann-La Roche (1) · SynOx Therapeutics Limited (1)
Belgium (2) · France (2) · Italy (2) · South Korea (2) · Spain (2) · United States (2) · Australia (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Czechia (1) · Denmark (1) · Germany (1) · Greece (1)
2023 (1)